メインコンテンツにスキップ
検索

早期臨床

登録

最新のリソース

注目コンテンツ

Upcoming early clinical webinars

Latest early clinical blogs

医薬品開発におけるPK/PDモデリングのための機械学習
Machine Learning for PK/PD Modeling in Drug DevelopmentBlog

医薬品開発におけるPK/PDモデリングのための機械学習

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法
How the US FDA MIDD paired pilot program helps sponsorsBlog

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法

指標となる臨床的薬剤相互作用研究における代謝物の測定
Measuring metabolites in index clinical DDI studiesBlog

指標となる臨床的薬剤相互作用研究における代謝物の測定

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters
Why FDA’s omaveloxolone approval for Friedreich’s ataxia mattersBlog

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters

Key development considerations for cell therapies
Key development considerations for cell therapiesBlog

Key development considerations for cell therapies

医薬品開発のリスク軽減：早期開発における重要な化学、製造、および管理（CMC）および生理学的薬物動態（PBPK）アプローチ
De-risking Drug Development: Key Chemistry, Manufacturing, and Controls (CMC) and Physiologically Based Pharmacokinetic (PBPK) Approaches in Early Development Blog

医薬品開発のリスク軽減：早期開発における重要な化学、製造、および管理（CMC）および生理学的薬物動態（PBPK）アプローチ

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

Bio-IT World Conference and Expo US 2026

May 19 - 21, 2026 – Omni Boston Hotel at the Seaport in Boston, MA – Booth 401
展示会・学会

2026 SNMMI Annual Meeting

May 30 - 2026年6月2日 – Los Angeles, CA
展示会・学会

ASCO Annual Meeting 2026

May 30 - 2026年6月2日 – Chicago, IL – Booth #17141

All early clinical resources

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Phoenix8.8の新機能

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Advancing Bayesian Methods in Clinical Trials

Certara Services, Press Coverage, Video

Building Trust in Data – Transparency, Traceability, and the Human Element

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Webinar

Understanding and Calculating Steady State Pharmacokinetics

サターラの製品 - Phoenix、モデリングおよびシミュレーション - PK/PD、ブログ、ナレッジベース

How does Pinnacle 21 Enterprise differ from the Community version?

Certara Products - Pinnacle 21, Blog

ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Conference

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Marbach DDI Workshop 2026

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Modeling and Simulation - PBPK, Conference

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Rare and Neglected Diseases, Blog
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software